XML 110 R46.htm IDEA: XBRL DOCUMENT v3.25.4
Earnings Per Ordinary Share (Tables)
12 Months Ended
Sep. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Reconciliation of Basic and Diluted

The following table presents a reconciliation of basic and diluted earnings per share for the years ended September 30, 2025, 2024 and 2023:

 

   For the Years Ended September 30, 
   2025   2024   2023 
Numerator:            
Net income  $1,381,245   $3,419,835   $2,878,230 
Less: net income (loss) attributable to non-controlling interest   189,948    (256,092)   
-
 
Net income attributable to Jin Medical International Ltd.  $1,191,297   $3,675,927   $2,878,230 
Denominator:               
Weighted average shares outstanding - basic and diluted *   156,547,100    156,474,149    145,136,980 
                
Earnings per Ordinary Share               
-Basic and diluted  $0.01   $0.02   $0.02 

 

* Retrospectively restated for effect of a 20-for-1 forward split on February 8, 2024.